anticorps (1) évaluation (1) effet (1) cytotoxicité (1) ligne (1) cancer (1) Development (1) Complement (1) Chemotherapy (1) Control (1) Cancer (1) Methods (1) Complement activation (1) Multidimensional Aptitude Battery (1) Strategy (1) Oligosaccharides (1) Lymphomas (1) Immunotherapy (1) Immunoglobulins (1) Immune response (1) Evaluation (1) Chemotherapy (1) Cancer (1) Monoclonal antibodies (1) Methods (1) Rituximab (1) Immunotherapy (1) Evaluation (1)